EmFace vs Morpheus8: Which Machine to Buy

Morpheus8 is the cheaper machine to own, at about €60,000 new against about €130,000 for EmFace, according to our machine page figures. EmFace costs more upfront, but it is needle-free and sells as a non-injectable lift, so the decision is as much about the patients you want as about the sticker price.

How do EmFace and Morpheus8 differ for patients?

InMode Morpheus8 is RF microneedling with burst mode and up to 4mm depth (8mm for the body tip). Our page notes it is the device patients ask for by name. BTL EmFace is a needle-free platform combining synchronised RF with HIFES muscle stimulation, positioned as a lift without injectables. Our page says the standard protocol is four twenty-minute sessions.

So the question is not which is better, but whether your patients want microneedling-style tightening or a no-downtime, no-needle option.

How much do EmFace and Morpheus8 cost?

A caution on the EmFace used range: our page says the used market is thin and resale pricing is not yet well established. A range that tops out above the new list price is a warning that there are very few data points. Do not treat the figure as a guide to what a particular unit is worth.

How quickly does each machine pay back?

Using the figures, gross margin per treatment (price minus consumable, before staff, rent and everything else):

• Morpheus8, mid-point: €450 session price minus €100 tip, about €350. At the extremes it ranges from about €150 (low price, high tip) to €550.
• EmFace: €500 minus €90, about €410.

Break-even in treatments, before overheads:

1. Morpheus8 new at €60,000: about 172 treatments at €350 margin.
2. Morpheus8 used at the middle of its range, €35,000: about 100 treatments.
3. EmFace new at €130,000: about 318 treatments at €410 margin.

EmFace earns slightly more per treatment but needs roughly twice as many treatments to cover the machine. Also note that a four-session protocol means a patient commits to a course. If the €500 figure is per session, a course is a sizeable sale; if it is for the course, your margin is very different. Confirm how BTL and local clinics define a "treatment" before relying on the numbers.

What else should a clinic weigh up?

• Tip control. Morpheus8 tips are only available through the official channel, so you cannot shop around. EmFace applicators are consumable and are the dominant running cost, with BTL supplying them directly. Either way you are tied to the manufacturer.
• Staffing and training. EmFace needs BTL certification. For Morpheus8, ask InMode and your insurer what is expected. Check with the HPRA and your insurer on who may perform treatments in your setting.
• Treatment time and diary. Four sessions of twenty minutes is easy to delegate and schedule, if your regulatory position allows it. Microneedling usually involves a longer appointment and downtime for the patient; confirm with the manufacturer.
• Resale. Morpheus8 has a better-defined used market. EmFace resale is uncertain precisely because few units have been sold on, which is a risk on a €130,000 outlay.

Which should your clinic buy?

Choose Morpheus8 if you want lower capital outlay, high patient recognition and a faster route to break-even, and you can handle the single-use tip cost. Choose EmFace if you specifically want a needle-free offer, have the capital or finance for it, and are willing to accept an uncertain resale value. If you are starting out and have only one slot in the budget, Morpheus8's lower entry and clearer used market make it the lower-risk machine on these figures. For clinics already running an injectables-heavy practice, EmFace's non-injectable positioning may fit in a way that the numbers alone do not show.

Related guides

Each machine has its own cost guide: Morpheus8 price in Ireland and EmFace price in Ireland. If you are leaning towards buying one second hand, see buying a Morpheus8 and buying an EmFace. The wider radiofrequency category lists other tightening platforms.

Next step: browse used units or list yours

Most clinics that want these platforms at lower cost look at used units first. Browse used listings to compare real asking prices against the ranges above. If you are replacing one with the other and have a machine to sell, list it free, no commission, or start with the seller guide.

Prices vary, so get written quotes and inspect any used unit before paying.

Sources and notes

• BTL Emface protocol and manufacturer-reported results, Plastic Surgery Practice: how EmFace combines RF with HIFES, the four-session course and the manufacturer's study claims.
• InMode FDA clearance announcement, July 2024, via BioSpace: what the company says its FDA 510(k) clearance for Morpheus8 covers.

Machine figures are Aesthetic Machines Ireland researched ranges, not completed-sale data. We could not open an independent Morpheus8 depth or downtime source, so treat those details as something to confirm with InMode.

Frequently asked questions

Is EmFace better than Morpheus8?

They do different jobs: EmFace is needle-free RF plus muscle stimulation, Morpheus8 is RF microneedling. Which is better depends on whether your patients want a no-needle option.

Is RF microneedling the same as Morpheus8?

Morpheus8 is one brand of RF microneedling, made by InMode, rather than the whole category. InMode describes it as fractional radiofrequency microneedling, and its July 2024 FDA clearance concerns soft tissue contraction and coagulation (BioSpace release). Other makers sell similar devices, so compare tips, depth range and support rather than the name.

How does EmFace work?

It delivers radiofrequency and HIFES (facial muscle stimulation) at the same time through applicators on the face. The RF heats collagen and elastin, while HIFES sends pulses that contract the muscles (Plastic Surgery Practice). The results quoted there are BTL's own, so ask for the underlying studies before relying on them.

How many EmFace sessions make up a course?

The recommended course is four 20-minute sessions spaced 2 to 14 days apart, per the same article. It describes the treatment as needle-free with no downtime. That fixed course matters when you price it, because your revenue per patient is a course, not one visit.

Which is cheaper to buy, EmFace or Morpheus8?

Morpheus8, at about €60,000 new against about €130,000 for EmFace on our machine page figures. Running costs also differ: €50 to €150 per single-use Morpheus8 tip against about €90 for EmFace applicators.

Which pays back faster?

On our figures Morpheus8 needs fewer treatments to cover the machine, roughly 172 against 318 for new units, before overheads. Your own pricing and diary decide the real answer.

Can I buy either machine used?

Yes. Morpheus8 has a clearer used market at €25,000 to €45,000, while EmFace used pricing is thin and unreliable. Inspect carefully and confirm with the maker whether warranty and applicator access transfer.

What should I ask a seller of a used EmFace or Morpheus8?

Ask for the service history, how many applicators or tips remain and whether the maker will support the unit for a new owner. Ask for a full demonstration and check certification requirements with BTL or InMode and your insurer.